表紙:シーケンシング試薬の世界市場予測(2021年~2028年)
市場調査レポート
商品コード
1025633

シーケンシング試薬の世界市場予測(2021年~2028年)

Global Sequencing Reagents Market Forecast 2021-2028

出版日: | 発行: Inkwood Research | ページ情報: 英文 258 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.75円
シーケンシング試薬の世界市場予測(2021年~2028年)
出版日: 2021年09月01日
発行: Inkwood Research
ページ情報: 英文 258 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のシーケンシング試薬市場規模は、2021年から2028年の間に12.91%のCAGRで成長すると予測されています。

本市場は、先進的なシーケンシング手法の開発、慢性疾患の蔓延によるゲノミクス研究の活発化、政府やメーカーによるゲノミクスへの継続的な投資などが成長を後押ししています。しかし、有能な専門家の不足やデータのプライバシー問題が、シーケンシング試薬市場の成長を妨げています。

当レポートでは、世界のシーケンシング試薬市場について調査しており、市場力学、市場分析、地域分析、競合情勢、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 調査範囲および方法調査手法

  • 調査目的
  • 調査範囲
  • 調査手法
  • 仮定および制限

第2章 エグゼクティブサマリー

  • 市場規模・推計
  • 市場概要

第3章 市場力学

  • 主要促進要因
    • 高度なシーケンシング方法によるシーケンシング手順コストの削減
    • ゲノミクスにおける製造業者および政府別継続的な資金提供
    • 慢性疾患の有病率
  • 主要抑制要因
    • 十分な知識を持つ専門家の不足
    • データプライバシーに関連する社会的および倫理的問題

第4章 主要分析

  • COVID-19がシーケンシング試薬市場に与える影響
  • 動向
  • ポーターのファイブフォース分析
    • 買い手の交渉力
    • サプライヤの交渉力
    • 代替製品
    • 新規参入企業
    • 既存企業間の競合関係
  • サプライチェーン分析
  • 市場機会マトリックス
  • ベンダー情勢

第5章 市場:技術別

  • 次世代シーケンス
  • サンガーシーケンシング
  • 第三世代シーケンシング

第6章 市場:試薬タイプ別

  • シーケンシングキット
  • コントロールキット
  • ライブラリキット
  • テンプレートキット
  • その他の試薬タイプ

第7章 市場:アプリケーション別

  • 腫瘍学
  • 臨床調査
  • アグリゲノミクスと法医学
  • リプロダクティブ・ヘルス
  • その他のアプリケーション

第8章 市場:エンドユーザー別

  • 調査
  • 病院およびクリニック
  • 製薬およびバイオテクノロジー企業
  • その他のエンドユーザー

第9章 地域分析

  • 北米
    • 市場規模・推計
    • 主要成長イネーブラー
    • 主要課題
    • 主要企業
    • 国別分析
  • 欧州
    • 市場規模・推計
    • 主要成長イネーブラー
    • 主要課題
    • 主要企業
    • 国別分析
  • アジア太平洋
    • 市場規模・推計
    • 主要成長イネーブラー
    • 主要課題
    • 主要企業
    • 国別分析
  • その他の地域
    • 市場規模・推計
    • 主要成長イネーブラー
    • 主要課題
    • 主要企業
    • 地域分析

第10章 競合情勢

  • 主な戦略的開発
    • 合併および買収
    • 製品の発売および開発
    • 提携および契約
    • 事業の拡大、発表、売却
  • 企業プロファイル
    • AGILENT TECHNOLOGIES INC
    • ASURAGEN INC
    • BGI GENOMICS
    • BIO-RAD LABORATORIES INC
    • F. HOFFMANN-LA ROCHE
    • FLUIDIGM CORPORATION
    • ILLUMINA INC
    • LGC BIOSEARCH TECHNOLOGIES
    • MERCK KGAA
    • PACIFIC BIOSCIENCES OF CALIFORNIA INC
    • PERKINELMER INC
    • QIAGEN NV
    • TAKARA BIO INC
    • THERMO FISHER SCIENTIFIC INC
    • TRILINK BIOTECHNOLOGIES INC
図表

LIST OF TABLES

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SEQUENCING REAGENTS
  • TABLE 2: GLOBAL SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL SANGER SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL SANGER SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL THIRD-GENERATION SEQUENCING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL THIRD-GENERATION SEQUENCING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL SEQUENCING KITS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL SEQUENCING KITS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL CONTROL KITS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL CONTROL KITS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL LIBRARY KITS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL LIBRARY KITS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL TEMPLATE KITS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL TEMPLATE KITS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL OTHER REAGENT TYPES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL OTHER REAGENT TYPES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL SEQUENCING REAGENTS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL SEQUENCING REAGENTS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL ONCOLOGY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL ONCOLOGY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL CLINICAL INVESTIGATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL CLINICAL INVESTIGATION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL AGRI GENOMICS AND FORENSICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL AGRI GENOMICS AND FORENSICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL REPRODUCTIVE HEALTH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL REPRODUCTIVE HEALTH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL SEQUENCING REAGENTS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL SEQUENCING REAGENTS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 43: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 44: GLOBAL SEQUENCING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 45: GLOBAL SEQUENCING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 46: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: LEADING PLAYERS OPERATING IN NORTH AMERICA SEQUENCING REAGENTS MARKET
  • TABLE 49: EUROPE SEQUENCING REAGENTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 50: EUROPE SEQUENCING REAGENTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 51: LEADING PLAYERS OPERATING IN EUROPE SEQUENCING REAGENTS MARKET
  • TABLE 52: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 53: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 54: LEADING PLAYERS OPERATING IN ASIA-PACIFIC SEQUENCING REAGENTS MARKET
  • TABLE 55: REST OF WORLD SEQUENCING REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 56: REST OF WORLD SEQUENCING REAGENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 57: LEADING PLAYERS OPERATING IN REST OF WORLD SEQUENCING REAGENTS MARKET
  • TABLE 58: LIST OF MERGERS & ACQUISITIONS
  • TABLE 59: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 60: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 61: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

LIST OF FIGURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, IN 2020
  • FIGURE 6: GLOBAL SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, IN 2020
  • FIGURE 10: GLOBAL SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL SEQUENCING REAGENTS MARKET, BY APPLICATION, IN 2020
  • FIGURE 16: GLOBAL SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL SEQUENCING REAGENTS MARKET, BY END-USER, IN 2020
  • FIGURE 22: GLOBAL SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL SEQUENCING REAGENTS MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
  • FIGURE 26: NORTH AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 27: UNITED STATES SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: CANADA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: EUROPE SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 30: GERMANY SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: FRANCE SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: UNITED KINGDOM SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: ITALY SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: RUSSIA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: POLAND SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: BELGIUM SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 37: REST OF EUROPE SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: ASIA-PACIFIC SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 39: CHINA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: JAPAN SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: INDIA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: AUSTRALIA & NEW ZEALAND SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: SOUTH KOREA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: INDONESIA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: THAILAND SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: VIETNAM SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: REST OF ASIA-PACIFIC SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: REST OF WORLD SEQUENCING REAGENTS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 49: LATIN AMERICA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
目次
Product Code: 40035

KEY FINDINGS

The global sequencing reagents market is estimated to record a CAGR of 12.91% during the forecast period, 2021-2028. The development of advanced sequencing methods, rising genomics research due to prevailing chronic diseases, and consistent investments in genomics by the government and manufacturers propel market growth.

MARKET INSIGHTS

Sequencing reagents are central to sequencing reactions and find varied applications. Genome sequencing costs have reduced drastically in the past seven years. For example, the first whole human genome sequencing cost was valued at over US$ 3.7 billion in 2000, taking more than a decade for completion. At present, the prices have come down to US$ 1000 and require only a fewer number of days. Also, the minimized costs of testing services have rendered a large margin in profits and faster process regarding the high load of consumers. In addition, the lowered prices have aided in clinical research, along with facilitating the launch of health startups. Moreover, the market players have launched several breakthrough technologies that have enabled time and cost minimization in sequencing. At the same time, the lack of competent professionals and data privacy issues hinder the sequencing reagents market growth.

REGIONAL INSIGHTS

The global sequencing reagents market growth evaluation includes the geographical assessment of North America, Asia-Pacific, Europe, and Rest of World. North America dominates the global market with the largest revenue share. The decreasing cost of sequencing procedures and increased funding activities for research studies drive market growth.

COMPETITIVE INSIGHTS

The adoption of advanced technologies, competitive pricing, and innovations propel the intense competitive rivalry. BGI Genomics, F. Hoffmann-La Roche, Bio-Rad Laboratories Inc, Asuragen Inc, Agilent Technologies Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. ADVANCED SEQUENCING METHODS LOWER THE COST OF SEQUENCING PROCEDURES
    • 3.1.2. CONTINUOUS FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
    • 3.1.3. PREVALENCE OF CHRONIC DISEASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE
    • 3.2.2. SOCIAL AND ETHICAL ISSUES RELATED TO THE DATA PRIVACY

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRY
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. SUPPLY CHAIN ANALYSIS
  • 4.5. OPPORTUNITY MATRIX
  • 4.6. VENDOR LANDSCAPE

5. MARKET BY TECHNOLOGY

  • 5.1. NEXT-GENERATION SEQUENCING
  • 5.2. SANGER SEQUENCING
  • 5.3. THIRD-GENERATION SEQUENCING

6. MARKET BY REAGENT TYPE

  • 6.1. SEQUENCING KITS
  • 6.2. CONTROL KITS
  • 6.3. LIBRARY KITS
  • 6.4. TEMPLATE KITS
  • 6.5. OTHER REAGENT TYPES

7. MARKET BY APPLICATION

  • 7.1. ONCOLOGY
  • 7.2. CLINICAL INVESTIGATION
  • 7.3. AGRI GENOMICS AND FORENSICS
  • 7.4. REPRODUCTIVE HEALTH
  • 7.5. OTHER APPLICATIONS

8. MARKET BY END-USER

  • 8.1. RESEARCH INSTITUTES
  • 8.2. HOSPITALS AND CLINICS
  • 8.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. MARKET SIZE & ESTIMATES
    • 9.2.2. KEY GROWTH ENABLERS
    • 9.2.3. KEY CHALLENGES
    • 9.2.4. KEY PLAYERS
    • 9.2.5. COUNTRY ANALYSIS
      • 9.2.5.1. GERMANY
      • 9.2.5.2. FRANCE
      • 9.2.5.3. UNITED KINGDOM
      • 9.2.5.4. ITALY
      • 9.2.5.5. RUSSIA
      • 9.2.5.6. POLAND
      • 9.2.5.7. BELGIUM
      • 9.2.5.8. REST OF EUROPE
  • 9.3. ASIA-PACIFIC
    • 9.3.1. MARKET SIZE & ESTIMATES
    • 9.3.2. KEY GROWTH ENABLERS
    • 9.3.3. KEY CHALLENGES
    • 9.3.4. KEY PLAYERS
    • 9.3.5. COUNTRY ANALYSIS
      • 9.3.5.1. CHINA
      • 9.3.5.2. JAPAN
      • 9.3.5.3. INDIA
      • 9.3.5.4. AUSTRALIA & NEW ZEALAND
      • 9.3.5.5. SOUTH KOREA
      • 9.3.5.6. INDONESIA
      • 9.3.5.7. THAILAND
      • 9.3.5.8. VIETNAM
      • 9.3.5.9. REST OF ASIA-PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. MARKET SIZE & ESTIMATES
    • 9.4.2. KEY GROWTH ENABLERS
    • 9.4.3. KEY CHALLENGES
    • 9.4.4. KEY PLAYERS
    • 9.4.5. REGIONAL ANALYSIS
      • 9.4.5.1. LATIN AMERICA
      • 9.4.5.2. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS & AGREEMENTS
    • 10.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
  • 10.2. COMPANY PROFILES
    • 10.2.1. AGILENT TECHNOLOGIES INC
    • 10.2.2. ASURAGEN INC
    • 10.2.3. BGI GENOMICS
    • 10.2.4. BIO-RAD LABORATORIES INC
    • 10.2.5. F. HOFFMANN-LA ROCHE
    • 10.2.6. FLUIDIGM CORPORATION
    • 10.2.7. ILLUMINA INC
    • 10.2.8. LGC BIOSEARCH TECHNOLOGIES
    • 10.2.9. MERCK KGAA
    • 10.2.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
    • 10.2.11. PERKINELMER INC
    • 10.2.12. QIAGEN NV
    • 10.2.13. TAKARA BIO INC
    • 10.2.14. THERMO FISHER SCIENTIFIC INC
    • 10.2.15. TRILINK BIOTECHNOLOGIES INC